# In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route

> **NCT02082379** · NA · COMPLETED · sponsor: **Arkansas Children's Hospital Research Institute** · enrollment: 21 (actual)

## Conditions studied

- Interface Acceptance During Delivery of Aerosol Medicine to an Infant or Child

## Interventions

- **BEHAVIORAL:** inhaled normal saline using different interfaces.

## Key facts

- **NCT ID:** NCT02082379
- **Lead sponsor:** Arkansas Children's Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02082379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02082379, "In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02082379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*